The SARS-CoV-2 main protease (Mpro) is a medicinal chemistry target for COVID-19 treatment. Given the clinical efficacy of β-lactams as inhibitors of bacterial nucleophilic enzymes, they are of interest as inhibitors of viral nucleophilic serine and cysteine proteases. We describe the synthesis of penicillin derivatives which are potent Mpro inhibitors and investigate their mechanism of inhibition using mass spectrometric and crystallographic analyses. The results suggest that β-lactams have considerable potential as Mpro inhibitors via a mechanism involving reaction with the nucleophilic cysteine to form a stable acyl-enzyme complex as shown by crystallographic analysis. The results highlight the potential for inhibition of viral proteases employing nucleophilic catalysis by β-lactams and related acylating agents.
Journal article
2022-06-09T00:00:00+00:00
65
7682 - 7696
14
Antiviral Agents, Coronavirus 3C Proteases, Cysteine, Cysteine Endopeptidases, Humans, Penicillins, Protease Inhibitors, SARS-CoV-2, beta-Lactams, COVID-19 Drug Treatment